Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced participation in two virtual investor conferences. The H.C. Wainwright Virtual BioConnect 2022 Conference will feature an on-demand presentation from January 10 to January 13, 2022. Additionally, the J.P. Morgan 40th Annual Healthcare Conference will host a presentation on January 13, 2022, at 9:45 am EST. Interested individuals can access these presentations via the 'Investors' section on the Aurinia corporate website, which also provides further details on the company's focus in the biopharmaceutical industry.

VICTORIA, British Columbia--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences.

• H.C. Wainwright Virtual BioConnect 2022 Conference. On-demand presentation available Monday, January 10, 2022, beginning at 7:00 a.m. EST thru Thursday, January 13, 2022 (access here)
• J.P Morgan 40^th Annual Healthcare Conference. Presentation to be hosted on Thursday, January 13, 2022 at 9:45 am EST (access here)

Interested parties can also register and access these presentations under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com.

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005906/en/

Investor and Corporate:

Dana Lynch, Corporate Communications & IR

dlynch@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

FAQ

When will Aurinia Pharmaceuticals present at the H.C. Wainwright Virtual BioConnect 2022 Conference?

Aurinia Pharmaceuticals will present on-demand from January 10 to January 13, 2022.

What is the date and time of Aurinia's presentation at the J.P. Morgan 40th Annual Healthcare Conference?

Aurinia's presentation at the J.P. Morgan Conference is scheduled for January 13, 2022, at 9:45 am EST.

Where can I access the presentations for Aurinia Pharmaceuticals' investor conferences?

The presentations can be accessed under the 'News/Events' section on Aurinia's corporate website.

What significant product did Aurinia Pharmaceuticals launch in January 2021?

In January 2021, Aurinia launched the first FDA-approved oral therapy for active lupus nephritis.

What is the stock symbol for Aurinia Pharmaceuticals?

The stock symbol for Aurinia Pharmaceuticals is AUPH.